Status:
COMPLETED
Clinical Characteristics of Patients With Leukemia and COVID-19
Lead Sponsor:
Hospital General de Mexico
Conditions:
Leukemia, Acute
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to describe the main clinical characteristics of patients with de novo acute lymphoblastic leukemia treated inside the third level hospitals converted to Coronavirus disea...
Detailed Description
Retrospective, observational study in patients with diagnosis of acute lymphoblastic leukemia, according to the criteria of the World Health Organization, from April 2020 to December 2020. Patients wa...
Eligibility Criteria
Inclusion
- Patients with diagnosis of acute lymphoblastic leukemia according to the criteria of the World Health Organization.
Exclusion
- Age less than 18 years
- Incomplete medical records
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 25 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04745416
Start Date
January 1 2020
End Date
January 25 2021
Last Update
February 9 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Regional de Alta Especialidad de Ixtapaluca
Ixtapaluca, State of Mexico, Mexico, 56530
2
Hospital General de México "Dr. Eduardo Liceaga"
Mexico City, Mexico, 06720